Nexgel (NXGL)

Nexgel on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.

Download CSV

105K

Short interest

settlement 2026-10-15

1.0

Days to cover

unchanged vs prior

72.3%

Short share of volume

2026-11-02

3,546

Fails to deliver

settlement 2026-10-14

Wed 11 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in NXGL is 104,742 shares, down 92,597 shares over the last month. Over the last 48 readings it ranged from 1,173 shares (30 January 2026) to 395,627 shares (31 August 2026). At the reported average volume of 404K shares a day that is 1.0 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/nxgl" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	104,742	-67.5%	404,159	1.00
2026-09-30	322,449	+63.4%	588,839	1.00
2026-09-15	197,339	-50.1%	243,093	1.00
2026-08-31	395,627	+47.3%	2,550,427	1.00
2026-08-14	268,561	+104.7%	565,157	1.00
2026-07-31	131,227	-23.7%	48,160	2.72
2026-07-15	171,997	-2.7%	177,158	1.00
2026-06-30	176,789	+333.8%	830,784	1.00
2026-06-15	40,752	-61.8%	130,920	1.00
2026-05-29	106,691	-45.5%	172,013	1.00
2026-05-15	195,747	-41.7%	115,076	1.70
2026-04-30	335,976	+175.8%	543,697	1.00
2026-04-15	121,810	+43.2%	151,076	1.00
2026-03-31	85,078	-57.5%	142,821	1.00
2026-03-13	200,109	+4758.2%	1,243,967	1.00
2026-02-27	4,119	+72.1%	30,716	1.00
2026-02-13	2,393	+104.0%	52,756	1.00
2026-01-30	1,173	-87.0%	37,621	1.00
2026-01-15	9,023	+5.7%	32,887	1.00
2025-12-31	8,539	+55.2%	59,368	1.00
2025-12-15	5,503	-75.9%	106,083	1.00
2025-11-28	22,846	-49.6%	70,785	1.00
2025-11-14	45,361	+59.8%	101,962	1.00
2025-10-31	28,382	+1.4%	70,356	1.00
2025-10-15	27,990	-32.0%	48,380	1.00
2025-09-30	41,178	+32.9%	34,289	1.20
2025-09-15	30,985	-15.8%	55,141	1.00
2025-08-29	36,792	+2.9%	37,034	1.00
2025-08-15	35,751	+3.6%	64,885	1.00
2025-07-31	34,501	-43.2%	64,140	1.00
2025-07-15	60,752	-3.5%	21,947	2.77
2025-06-30	62,926	+20.4%	36,313	1.73
2025-06-13	52,286	+0.8%	52,584	1.00
2025-05-30	51,863	-23.6%	46,002	1.13
2025-05-15	67,913	-6.3%	33,458	2.03
2025-04-30	72,494	-28.1%	24,669	2.94
2025-04-15	100,770	-34.9%	33,990	2.96
2025-03-31	154,852	+42.3%	43,648	3.55
2025-03-14	108,829	+5.2%	65,468	1.66
2025-02-28	103,499	-2.7%	72,243	1.43
2025-02-14	106,353	-18.9%	66,703	1.59
2025-01-31	131,050	+14.6%	99,370	1.32
2025-01-15	114,311	-12.4%	175,852	1.00
2024-12-31	130,440	+14.9%	134,698	1.00
2024-12-13	113,519	+167.4%	204,134	1.00
2024-11-29	42,459	-59.5%	52,560	1.00
2024-11-15	104,811	+310.3%	128,903	1.00
2024-10-31	25,547	-10.9%	66,377	1.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of NXGL volume is 72.3%, up 44.3 points over the last five sessions. Over the last 30 readings it ranged from 6.1% (23 September 2026) to 79.0% (6 October 2026). The latest reading sits at the top of that range. The latest reading is 22.4 points above the 30-session average of 49.8%, on 10K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	8K	10K	72.3%	1,373
2026-10-30	9K	16K	53.7%	26
2026-10-29	4K	8K	50.3%	31
2026-10-28	7K	25K	26.2%	218
2026-10-27	3K	7K	36.9%	515
2026-10-26	7K	24K	27.9%	540
2026-10-23	4K	9K	43.0%	42
2026-10-22	4K	10K	37.8%	391
2026-10-21	7K	14K	49.9%	187
2026-10-20	4K	13K	33.7%	415
2026-10-19	3K	10K	32.9%	80
2026-10-16	14K	36K	40.4%	171
2026-10-15	39K	72K	54.4%	13,280
2026-10-14	958K	1.6M	59.5%	19,795
2026-10-13	26K	51K	51.5%	6,158
2026-10-12	74K	118K	62.4%	9,499
2026-10-09	2.7M	4.5M	60.3%	628,301
2026-10-08	491K	794K	61.8%	57,474
2026-10-07	194K	278K	69.8%	0
2026-10-06	139K	176K	79.0%	0
2026-10-05	134K	231K	58.1%	9,330
2026-10-02	90K	139K	64.4%	0
2026-10-01	166K	258K	64.4%	0
2026-09-30	97K	226K	42.9%	1,700
2026-09-29	99K	159K	62.4%	2,200
2026-09-28	214K	513K	41.7%	54,329
2026-09-25	676K	1.3M	51.1%	73,189
2026-09-24	26K	80K	32.8%	0
2026-09-23	4K	64K	6.1%	0
2026-09-22	6K	8K	66.9%	0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in NXGL is 3,546 shares, down 22,458 shares over the last settlement date. Over the last 30 readings it ranged from 239 shares (9 September 2026) to 274,808 shares (25 August 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-14	3,546	$4.05	$14K
2026-10-13	26,004	$3.81	$99K
2026-10-08	9,022	$0.18	$2K
2026-10-07	4,612	$0.17	$784
2026-09-29	1,344	$0.18	$242
2026-09-28	10,340	$0.17	$2K
2026-09-25	2,874	$0.26	$747
2026-09-24	597	$0.27	$161
2026-09-23	524	$0.27	$141
2026-09-18	71,690	$0.25	$18K
2026-09-17	41,940	$0.25	$10K
2026-09-16	7,911	$0.28	$2K
2026-09-14	250	$0.29	$73
2026-09-11	3,523	$0.29	$1K
2026-09-10	412	$0.30	$124
2026-09-09	239	$0.30	$72
2026-09-04	28,107	$0.34	$10K
2026-09-03	27,789	$0.35	$10K
2026-09-02	8,501	$0.36	$3K
2026-08-31	2,402	$0.35	$841
2026-08-28	3,160	$0.35	$1K
2026-08-26	127,739	$0.36	$46K
2026-08-25	274,808	$0.38	$104K
2026-08-24	12,372	$0.33	$4K
2026-08-21	2,702	$0.39	$1K
2026-08-17	24,888	$0.57	$14K
2026-08-14	6,557	$0.49	$3K
2026-08-13	4,217	$0.41	$2K
2026-08-12	4,363	$0.43	$2K
2026-08-06	2,319	$0.40	$928

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for NXGL in the last 90 days. The most recent filings are listed below. Latest filing: Levy Adam R. (Chief Executive Officer) on 2026-06-23.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-06-23	Levy Adam R.	Chief Executive Officer	Sell	5K	$0.59	$3K	323K
2026-06-18	Levy Adam R.	Chief Executive Officer	Sell	6K	$0.59	$4K	328K
2026-06-11	Levy Adam R.	Chief Executive Officer	Sell	3K	$0.61	$2K	334K
2026-06-08	Levy Adam R.	Chief Executive Officer	Sell	3K	$0.55	$2K	337K
2026-06-04	Levy Adam R.	Chief Executive Officer	Sell	3K	$0.59	$2K	340K
2026-06-01	Levy Adam R.	Chief Executive Officer	Sell	2K	$0.59	$1K	343K
2026-05-29	Levy Adam R.	Chief Executive Officer	Sell	3K	$0.60	$2K	345K
2026-05-28	Levy Adam R.	Chief Executive Officer	Sell	7K	$0.61	$4K	348K
2026-05-27	Levy Adam R.	Chief Executive Officer	Sell	3K	$0.60	$2K	355K
2025-12-24	Levy Adam R.	Chief Executive Officer	Sell	4K	$1.57	$6K	358K
2025-12-22	Levy Adam R.	Chief Executive Officer	Sell	6K	$1.61	$10K	362K
2025-11-06	Levy Adam R.	Chief Executive Officer	Sell	4K	$2.52	$10K	368K
2025-10-03	Levy Adam R.	Chief Executive Officer	Sell	2K	$2.55	$6K	372K
2025-10-03	Henry Scott Robert	Director	Sell	7K	$2.55	$18K	113K
2025-10-02	Levy Adam R.	Chief Executive Officer	Sell	2K	$2.50	$4K	374K
2025-10-02	Henry Scott Robert	Director	Sell	825	$2.50	$2K	121K
2025-09-25	Henry Scott Robert	Director	Sell	8K	$2.36	$18K	121K
2025-08-28	Levy Adam R.	Chief Executive Officer	Sell	4K	$2.47	$10K	358K
2025-06-13	Henry Scott Robert	Director	Sell	3K	$2.57	$8K	129K
2025-06-11	Levy Adam R.	Chief Executive Officer	Sell	2K	$2.39	$5K	362K
2025-06-09	Levy Adam R.	Chief Executive Officer	Sell	2K	$2.33	$5K	364K
2025-06-05	Levy Adam R.	Chief Executive Officer	Sell	1K	$2.32	$2K	366K
2025-06-04	Levy Adam R.	Chief Executive Officer	Sell	1K	$2.29	$2K	367K
2025-05-30	Levy Adam R.	Chief Executive Officer	Sell	1K	$2.22	$2K	368K
2025-05-16	Levy Adam R.	Chief Executive Officer	Sell	1K	$2.58	$3K	369K
2025-05-12	Henry Scott Robert	Director	Sell	3K	$2.69	$8K	132K
2025-04-10	Henry Scott Robert	Director	Sell	3K	$2.61	$8K	135K
2025-04-01	Levy Adam R.	Chief Executive Officer	Sell	4K	$3.01	$12K	370K
2025-03-10	Henry Scott Robert	Director	Sell	3K	$2.87	$9K	138K
2025-03-03	Levy Adam R.	Chief Executive Officer	Sell	4K	$3.16	$13K	374K
2025-02-12	Henry Scott Robert	Director	Grant	3K	$0.00	$0	141K
2025-02-12	glassman steven mark	Director	Grant	3K	$0.00	$0	157K
2025-02-10	Henry Scott Robert	Director	Sell	3K	$3.27	$10K	139K
2025-02-03	Levy Adam R.	Chief Executive Officer	Sell	4K	$3.64	$15K	378K
2025-01-07	Henry Scott Robert	Director	Sell	3K	$3.37	$10K	142K
2025-01-02	Levy Adam R.	Chief Executive Officer	Sell	4K	$3.96	$16K	382K
2025-01-02	Levy Adam R.	Chief Executive Officer	Grant	26K	$0.00	$0	386K
2024-12-20	Henry Scott Robert	Director	Sell	3K	$4.64	$14K	145K
2024-11-20	Levy Adam R.	Chief Executive Officer	Buy	4K	$2.75	$10K	333K
2024-11-20	Henry Scott Robert	Director	Buy	2K	$2.75	$5K	148K
2024-11-20	Drapczuk Adam E III	Chief Financial Officer	Buy	18K	$2.75	$48K	75K
2024-11-20	glassman steven mark	Director	Buy	9K	$2.75	$25K	154K
2024-11-20	Stein John Nachum	Director	Buy	4K	$2.75	$10K	471K
2024-11-20	ZELDIS JEROME B	Director	Buy	4K	$2.75	$10K	107K
2024-11-07	Stein John Nachum	Director	Gift	4K	$0.00	$0	468K
2024-08-23	Drapczuk Adam E III	Chief Financial Officer	Buy	10K	$2.50	$25K	57K
2024-08-23	Henry Scott Robert	Director	Buy	10K	$2.50	$25K	146K
2024-08-23	ZELDIS JEROME B	Director	Buy	10K	$2.50	$25K	103K
2024-08-23	glassman steven mark	Director	Buy	10K	$2.50	$25K	145K
2024-08-23	Stein John Nachum	Director	Buy	10K	$2.50	$25K	472K
2024-03-01	Drapczuk Adam E III	Chief Financial Officer	Buy	47K	$2.11	$100K	47K
2024-03-01	glassman steven mark	Director	Buy	12K	$2.11	$25K	135K
2024-03-01	Henry Scott Robert	Director	Buy	24K	$2.11	$50K	136K
2023-12-22	glassman steven mark	Director	Buy	4K	$2.20	$9K	123K
2023-09-26	Stein John Nachum	Director	Buy	3K	$1.96	$5K	500K
2023-09-14	Henry Scott Robert	Director	Buy	500	$2.27	$1K	112K
2023-09-13	Henry Scott Robert	Director	Buy	6K	$2.25	$14K	112K
2023-09-12	Henry Scott Robert	Director	Buy	4K	$2.28	$9K	106K
2023-08-22	Henry Scott Robert	Director	Buy	980	$1.92	$2K	102K
2023-08-21	Henry Scott Robert	Director	Buy	2K	$1.95	$4K	101K
2023-06-08	STEFANSKY DAVID	Director	Buy	1K	$2.22	$2K	50K
2023-06-08	Stein John Nachum	Director	Buy	5K	$2.28	$11K	497K
2023-06-08	Henry Scott Robert	Director	Buy	4K	$2.24	$8K	99K
2023-06-07	STEFANSKY DAVID	Director	Buy	2K	$2.50	$5K	49K
2023-06-07	Stein John Nachum	Director	Buy	5K	$2.69	$13K	492K
2023-06-02	Henry Scott Robert	Director	Buy	2K	$2.40	$5K	95K
2023-05-31	STEFANSKY DAVID	Director	Buy	2K	$2.42	$5K	47K
2023-05-31	Henry Scott Robert	Director	Buy	1K	$2.25	$2K	93K
2023-05-30	glassman steven mark	Director	Buy	4K	$2.38	$10K	119K
2023-05-30	STEFANSKY DAVID	Director	Buy	5K	$2.53	$13K	45K
2023-05-26	ZELDIS JEROME B	Director	Buy	5K	$2.34	$12K	93K
2023-05-24	Henry Scott Robert	Director	Buy	2K	$2.01	$4K	92K
2023-05-23	Henry Scott Robert	Director	Buy	1K	$1.90	$2K	90K
2023-05-22	Henry Scott Robert	Director	Buy	4K	$1.95	$8K	89K
2022-12-19	STEFANSKY DAVID	Director	Buy	5K	$1.59	$8K	40K
2022-12-12	STEFANSKY DAVID	Director	Buy	8K	$1.44	$11K	35K
2022-11-29	STEIN NACHUM	Director	Buy	3K	$1.67	$5K	487K
2022-11-29	STEIN NACHUM	Director	Buy	3K	$1.17	$4K	487K
2022-11-25	STEIN NACHUM	Director	Buy	2K	$1.20	$2K	484K
2022-11-23	STEIN NACHUM	Director	Buy	100	$1.20	$120	483K
2022-11-21	STEIN NACHUM	Director	Buy	2K	$1.17	$2K	483K
2022-08-30	Spinrad Yaakov	Director	Buy	2K	$1.68	$3K	2K
2022-08-30	STEFANSKY DAVID	Director	Buy	5K	$1.66	$8K	28K
2022-08-25	STEFANSKY DAVID	Director	Buy	5K	$1.73	$9K	23K
2022-08-16	STEFANSKY DAVID	Director	Buy	3K	$1.79	$4K	18K
2022-08-15	STEFANSKY DAVID	Director	Buy	3K	$1.90	$5K	15K
2022-06-24	STEFANSKY DAVID	Director	Buy	3K	$1.60	$5K	12K
2022-05-31	Drapczuk Adam E III	Chief Financial Officer	Buy	5K	$1.54	$8K	20K
2022-05-27	Drapczuk Adam E III	Chief Financial Officer	Buy	15K	$1.63	$24K	15K
2022-03-25	glassman steven mark	Director	Buy	6K	$1.87	$10K	115K
2022-03-25	STEIN NACHUM	Director	Buy	5K	$1.90	$10K	481K
2022-03-25	Levy Adam R.	CEO	Buy	1K	$1.89	$2K	295K
2022-03-25	ZELDIS JEROME B	Director	Buy	5K	$1.89	$10K	88K
2021-12-27	glassman steven mark	Director	Buy	5K	$5.49	$27K	110K
2021-12-27	STEFANSKY DAVID	Director	Buy	9K	$5.49	$50K	9K
2021-12-27	STEIN NACHUM	Director	Buy	28K	$5.49	$154K	476K
2021-12-27	Toledano Miranda Jayne	Director	Buy	2K	$5.49	$10K	2K
2021-12-27	ZELDIS JEROME B	Director	Buy	9K	$5.49	$50K	83K
2021-10-27	Levy Adam R.	CEO	Grant	1.4M	$0.00	$0	10.3M
2021-03-08	Levy Adam R.	CEO & CFO	Grant	1.4M	$0.00	$0	1.4M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

5 Form 144 notices on file for NXGL worth $195K at the prices reported; 1 in the last 90 days worth $3K. Latest: Levy Adam R. filed on 2026-09-30 to sell 21,500 shares ($3K) from 2026-09-29.

Filed	Seller	Shares	Market value	Of outstanding	Sale from	Broker
2026-09-30	Levy Adam R.Affilaite	22K	$3K	0.221%	2026-09-29	Charles Schwab & Co., Inc.
2026-05-27	Levy Adam R.Officer	50K	$27K	0.548%	2026-05-27	Charles Schwab Corp.
2025-12-22	Levy Adam R.Officer	10K	$16K	0.123%	2025-12-22	Charles Schwab Corp.
2025-10-02	Levy Adam R.Officer, Director	16K	$40K	0.198%	2025-10-02	THE CHARLES SCHWAB CORPORATION
2025-09-25	Henry Scott RobertDirector	36K	$108K	0.440%	2025-09-25	THE CHARLES SCHWAB CORPORATION

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

3 holders report 5% or more of NXGL in their latest filing, all on Schedule 13G (passive). The largest reported stake is Asymmetry Point LP at 8.8% of the class (745,000 shares), filed 2026-04-29 for an event on 2026-03-31.

Filed	Form	Holder	Shares	Of class	Event
2026-04-29	13G/Ano. 1	Asymmetry Point LPpartnership	745K	8.8%	2026-03-31
2026-04-29	13G/Ano. 1	Asymmetry Point Capital LLCother entity	745K	8.8%	2026-03-31
2026-04-29	13G/Ano. 1	Mr. Aviv Argamanindividual	745K	8.8%	2026-03-31

13F holders

Tracked managers holding NXGL at their latest 13F. JSON

1 of the 30 tracked managers held NXGL at their latest 13F, $21K in total at quarter-end prices. Citadel Advisors is the largest at $21K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Citadel Advisors	2026-06-30	41K	$21K	0.00%	new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Nexgel in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Nexgel (NXGL), SEC CIK 1468929, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Planned sales: SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-30.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-29.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-17.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-23.JSON and CSV
Company record: EDGAR filing index for CIK 1468929Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as surgical & medical instruments & apparatus

Other company pages

Datasets

Frequently Asked Questions

How much of NXGL is sold short?

104,742 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is NXGL's daily short volume?

On 2026-11-02, 7,543 of the 10,438 NXGL shares reported to FINRA were sold short, 72.3% of the day's reported volume. Short volume is a flow for one day, not a position.

Does NXGL have fails to deliver?

The SEC's latest file shows 3,546 NXGL shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.

Are NXGL insiders buying or selling?

No open-market insider trades were reported for NXGL in the last 90 days. The most recent filings are listed below. Latest filing: Levy Adam R. (Chief Executive Officer) on 2026-06-23.

Have NXGL insiders filed to sell?

5 Form 144 notices on file for NXGL worth $195K at the prices reported; 1 in the last 90 days worth $3K. Latest: Levy Adam R. filed on 2026-09-30 to sell 21,500 shares ($3K) from 2026-09-29.

Who owns 5% or more of NXGL?

Which tracked 13F managers own NXGL?

1 of the 30 tracked 13F managers held NXGL shares at their latest filing, $21K in all. The largest: Ken Griffin's Citadel Advisors (41K shares, $21K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.